Gilead Sciences Inc (GILD)

Debt-to-equity ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Long-term debt	US$ in thousands	23,189,000	22,957,000	25,179,000	28,645,000	22,094,000
Total stockholders’ equity	US$ in thousands	22,833,000	21,240,000	21,069,000	18,202,000	22,525,000
Debt-to-equity ratio		1.02	1.08	1.20	1.57	0.98

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $23,189,000K ÷ $22,833,000K
= 1.02

The debt-to-equity ratio of Gilead Sciences, Inc. has fluctuated over the past five years. In 2019 and 2023, the company had a debt-to-equity ratio of 1.09, indicating an equal proportion of debt and equity in its capital structure. However, in 2020, the ratio increased to 1.73, suggesting a higher level of debt relative to equity in that year.

Subsequently, the ratio decreased to 1.27 in 2021 and further to 1.19 in 2022, indicating a gradual improvement in the company's debt position relative to its equity. Overall, the trend in the debt-to-equity ratio of Gilead Sciences, Inc. shows some variability but also a general trend towards a lower reliance on debt financing compared to equity over the analyzed period.